Login to Your Account

Renovo Raises £21M To Move Compounds Through Phase II

By Nuala Moran

Wednesday, December 4, 2002
Renovo Ltd. raised £21 million in a second round funding that should enable it to take two compounds, one for accelerating wound healing and one for preventing scarring, to the end of Phase II studies, and to put another four compounds into Phase I testing. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription